Seems like we are not. No.
470k for sales and with a production cost of 360k that's an excessive production cost. No wonder they needed a cap raise.
I know it says it was higher because of increased production and also ramping up but still.
That production cost needs to come way down or we need another revenue off the iron ore to make this worth it.
Otherwise production cost, admin, and corporate costs will just keep eating everything up and leave nothing.
Switching to hold instead of buy until we see actual numbers of what we are selling waste for and what our production costs are.
- Forums
- ASX - By Stock
- Ann: Quarterly 5B Cash Flow Report
Seems like we are not. No. 470k for sales and with a production...
Featured News
Add FHS (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
-0.001(20.0%) |
Mkt cap ! $12.31M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.4¢ | $5.135K | 1.219M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 4815615 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 3003750 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 4815615 | 0.004 |
3 | 3800000 | 0.003 |
6 | 3900501 | 0.002 |
2 | 3800000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 3003750 | 2 |
0.006 | 8518987 | 5 |
0.007 | 479806 | 6 |
0.008 | 2923543 | 4 |
0.009 | 87199 | 1 |
Last trade - 14.49pm 12/11/2024 (20 minute delay) ? |
Featured News
FHS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online